Mitra Biotech, a company that develops and provides novel technologies that personalise cancer treatment, has raised $27.4 million (approx Rs 183 crore) in a Series-B funding co-led by Sequoia India and Washington-based Sands Capital Ventures, and with participation from Boston-based RA Capital M…